MITCHELL S. GOLDBERG, District Judge.
Currently pending before me is the Motion to Remand filed by Plaintiffs Shanisha Young and Atiba Kenyatta, individually and on behalf of their daughter Z.K., a minor. For the following reasons, the Motion will be granted and the case will be remanded to the Court of Common Pleas for Philadelphia County.
According to the facts set forth in the Complaint, Plaintiff Young was admitted to Temple University Hospital ("Temple") on the morning of February 27, 2016, for the birth of her child. The attending physician was Dr. Shweta Shrivatsa, and the residents from Temple assisting with the delivery were Dr. Scott Jordan and Dr. Erin Cavanaugh. The Complaint alleges that the doctors improperly diagnosed Plaintiff's condition and delayed delivery of the baby, resulting in severe brain damage to the child and scarring on Plaintiff's bladder.
Plaintiffs filed a Writ of Summons in the Court of Common Pleas in Philadelphia on February 26, 2018, and filed their Complaint on May 31, 2018. The Complaint alleges counts of negligence against Defendants Temple, Dr. Shrivatsa, and Drs. Jordan and Cavanaugh; corporate negligence against Temple; and negligent infliction of emotional distress against all Defendants.
On July 2, 2018, Temple removed the case to this Court, based on an assertion that Dr. Shrivatsa was a federal employee and is therefore subject to federal jurisdiction. Although the Attorney General had yet to deem Dr. Shrivatsa a federal employee, Temple averred that she was a Public Health Service ("PHS") employee of a federally-funded health clinic—Delaware Valley Community Health, Inc. ("DVCH")—which was subject to a shared coverage agreement with Temple, and that she was acting in the scope of her employment at the time of the delivery. Temple and the other doctors brought cross-claims against the United States and Dr. Shrivatsa for contribution and indemnity.
On August 3, 2018, Plaintiffs filed this motion to remand, alleging that Defendants had insufficiently proven that Dr. Shrivatsa was a federal employee. Thereafter, on August 15, 2018, the United States certified that Dr. Shrivatsa was a federal employee of the PHS pursuant to the Federally Supported Health Centers Assistance Act ("FSHCAA"), 42 U.S.C. § 233(g), and that she was acting within the scope of her employment at the time of the allegations.
Under 28 U.S.C. § 1441(a), a defendant may remove a civil action filed in a state court if the federal court would have had original jurisdiction over the action. 28 U.S.C. § 1441(a). A defendant seeking removal of an action must file a petition for removal with the district court within thirty days of a plaintiff's service of the complaint upon the defendant. 28 U.S.C. § 1446(b). The defendants bear the burden of establishing that removal jurisdiction is proper.
Once an action is removed, a plaintiff may challenge removal by moving to remand the case back to state court. 28 U.S.C. § 1447(c). Remand to the state court is appropriate for "(1) lack of district court subject matter jurisdiction or (2) a defect in the removal procedure."
As set forth above, Defendant Temple University Hospital's basis for removal to federal court was the FSHCAA, 42 U.S.C. § 233(a). That statute provides that the exclusive remedy for the medical malpractice of employees or contractors of the Public Health Service is the remedy provided against the United States under the Federal Tort Claims Act ("FTCA"). 42 U.S.C. § 233(a);
For an employee (in this case, a doctor), to be covered under the FTCA, the employee must be "deemed" an employee of the PHS. 42 U.S.C. § 233(g)(1)A). Section 233 sets forth this procedure:
42 U.S.C. § 233(c). Following the United States' certification and removal to federal court, as outlined above, the United States may move the court to dismiss the employee from the case and substitute the United States in his/her place.
The procedure outlined above was not followed in this case. Temple, not the United States, removed the case to federal court, and did so before the United States certified that Dr. Shrivatsa was a federal employee and was acting in the scope of her employment at the time of the incident in question. Thus, at the time of removal, there was no federal jurisdiction. Although the United States has now provided that certification, Temple filed its petition for removal on July 2, 2018, over one month prior to the certification from the United States.
The Eleventh Circuit faced a similar situation in
I find the Eleventh Circuit's analysis persuasive and applicable to the facts before me. At the time of removal, the United States had not yet deemed Dr. Shrivatsa a federal employee acting within the scope of her employment during the relevant time period, nor had Dr. Shrivatsa herself removed the case to federal court after a failure by the Attorney General to make an appearance in the case within fifteen days of the filing in state court. Instead, it was Temple that prematurely removed the case based on a belief that Dr. Shrivatsa had federal employee status. But the statute does not bestow this authority upon a third-party—only the United States and the employee have the statutory authority to remove pursuant to § 233. Accordingly, removal to federal court was improper.
While I recognize that jurisdiction in this case may ultimately be proper, I must apply the controlling statute, which dictates that the removal by Temple University Hospital deprived the court of subject matter jurisdiction. Moreover, because no federal subject matter jurisdiction existed based on the facts alleged in Plaintiffs' Complaint, this removal defect at issue is jurisdictional and thus not waivable. The Third Circuit has held that "[a]n irregularity in removal of a case to federal court is to be considered `jurisdictional' . . . if the case could not initially have been filed in federal court."
Accordingly, I will remand the case back to state court for further proceedings consistent with this opinion.